Reciprocal regulation of hMENA and TGF-β signaling in cancer-associated fibroblasts promotes EMT, immunosuppression, poor prognosis, and ICT resistance in NSCLC

Background Cancer-associated fibroblasts (CAFs) significantly impact cancer progression and CAF subtypes are key determinants of response to immune checkpoint therapy (ICT). The transforming growth factor-β (TGF-β) signaling is a main pathway in protumorigenic activity of CAFs and resistance to ICT....

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Paola Nisticò, Isabella Sperduti, Paolo Visca, Lorenzo D’Ambrosio, Francesca Paolini, Annalisa Tocci, Belinda Palermo, Anna Di Carlo, Francesca Di Modugno, Filippo Gallina, Roberta Melchionna, Giulia Campo, Riccardo Tajè, Daniel D’Andrea
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMJ Publishing Group 2026-01-01
Σειρά:	Journal for ImmunoTherapy of Cancer
Διαθέσιμο Online:	https://jitc.bmj.com/content/14/1/e013098.full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!